|
Effect | Plant compound/extract | Model | Disease/condition | Reference |
|
Antiapoptotic and/or cell viability | Anemopaegma mirandum extracts. | In vitro | Rotenone model in SH-SY5Y cells. | [137] |
Pueraria thomsonii. | In vitro | 6-OHDA model in PC12 cells. | [155] |
Cistanche salsa. | In vivo | MPP+ mice model. | [127] |
Gastrodia elata extract. | In vitro | MPP+ model in SH-SY5Y cells. | [141] |
Rosmarinus officinalis extract. | In vitro | Aβ model in cortical neurons. | [168] |
Chrysanthemum morifolium extract. | In vitro | MPP+ model in SH-SY5Y cells. | [126] |
Panax notoginseng. | In vitro | MPTP model in mesencephalic neurons. | [151] |
Piperine (Figure 2(d)). | In vitro | Rotenone model in SH-SY5Y cells. | [104] |
L-theanine, from green tea (Figure 3(b)). | In vitro | H2O2 model in SH-SY5Y cells. | [16] |
Toki-to, mixed medicinal herbs. | In vitro In vivo | 6-OHDA model in PC12 cells. 6-OHDA rat model. | [158] |
Nobiletin, a flavonoid from citrus peels. | In vitro In vivo | H2O2 model in PC12 cells. Rat artery occlusion model. | [95] |
Psoralea corylifolia. | In vitro In vivo | MPP+ model in CHO cells and SK-N-SH cells. MPTP mice and rat model. | [161] |
Chrysanthemum morifolium extract. | In vitro | MPP+ model in SH-SY5Y cell. | [126] |
Uncaria rhynchophylla extract. | In vitro | Rotenone model in SH-SY5Y cells. | [146] |
Polyphenolic extract from Vitis vinifera. | In vitro | Rotenone model in SH-SY5Y cells. | [93] |
Withania somnifera extract. | In vitro In vivo | MPP+ model in CHO cells and SK-N-SH cells. MPTP mice and rat model. | [154] |
Paeonol from Paeonia suffruticosa or Paeonia lactiflora. | In vitro In vivo | MPP+ model in PC12 cells. MPP+ mice model. | [14] |
Ipomoea batatas PoirCv. | In vitro | Aβ model in PC12 cells. | [121] |
Biotransformed blueberry juice by Serratia vaccinii bacteria. | In vitro | H2O2 model in neuronal cells. | [61] |
Polyphenolic from cocoa. | In vivo | Aged rats. | [76] |
Salvia miltiorrhiza. | In vitro In vivo | Cortical neurons overexpressing APP695. APP/PS1 transgenic mice. | [88] |
Opuntia dillenii. | In vitro In vivo | NMDA model in cortical neurons. Rat artery occlusion model. | [169] |
Selaginellin from Saussurea pulvinata. | In vivo | Aβ mice model. | [63] |
Mucuna pruriens. | In vivo | APP-SL 7-5 transgenic mice APP695. | [157] |
Urundeuvines A, B, and C chalcones from Myracrodruon urundeuva. | In vivo | 6-OHDA model in mesencephalic cells. | [147] |
|
Cell survival | Bacopa monnieri extract. | In vitro | Aβ model in cortical neurons. | [113] |
Dioscorea opposita. | In vitro In vivo | H2O2 or glutamate model in cortical neurons. Scopolamine mice model. | [106] |
Nobiletin, flavonoid from citrus peels. | In vitro In vivo | H2O2 model in PC12 cells. Rat artery occlusion model. | [95] |
Opuntia dillenii. | In vitro In vivo | NMDA model in cortical neurons. Rat artery occlusion model. | [169] |
Pelargonidin (Figure 1(o)). | In vivo | Ethylcholine aziridinium ion model (AF64A). | [133] |
Psoralea corylifolia. | In vitro In vivo | MPP+ model in CHO cells and SK-N-SH cells. MPTP mice and rat model. | [161] |
Withania somnifera extract. | In vitro In vivo | MPP+ model in CHO cells and SK-N-SH cells. MPTP mice and rat model. | [154] |
Paeonol from Paeonia suffruticosa or Paeonia lactiflora. | In vitro In vivo | MPP+ model in PC12 cells. MPP+ mice model. | [14] |
Pedicularioside A from Buddleia lindleyana. | In vivo | 6-OHDA rat model. | [145] |
Silybum marianum. | In vivo | MPTP mice model. | [172] |
Toki-to, mixed medicinal herbs. | In vitro In vivo | 6-OHDA model in PC12 cells. 6-OHDA rat model. | [158] |
Urundeuvines A, B and C chalcones from Myracrodruon urundeuva. | In vivo | 6-OHDA model in mesencephalic cells. | [147] |
Salvia miltiorrhiza. | In vitro In vivo | Cortical neurons overexpressing APP695. APP/PS1 transgenic mice. | [88] |
Centella asiatica extract. | In vivo | PSAPP mice. | [92] |
Ipomoea batatas PoirCv. | In vitro | Aβ model in PC12 cells. | [121] |
Mucuna pruriens. | In vivo | APP-SL 7-5 model in transgenic mice APP695. | [157] |
Valeriana officinalis extract. | In vivo | Tg2576 transgenic mice. | [138] |
Luteolin. | In vitro | LPS model in mesencephalic neuron-glia and microglia cells. | [143] |
Panax notoginseng. | In vitro | MPTP model in mesencephalic neuron. | [151] |
Piperine (Figure 2(d)). | In vitro | Rotenone model in SH-SY5Y cells. | [104] |
L-theanine, from green tea (Figure 3(b)). | In vitro | H2O2 model in SH-SY5Y cells. | [16] |
Tripterygium regelii methanolic extract. | In vitro | 6-OHDA model in mesencephalic cells. | [140] |
|
Antioxidant | Biotransformed blueberry juice by Serratia vaccinii bacteria. | In vitro | H2O2 model in neuronal cell. | [61] |
Rosmarinus officinalis. | In vitro In vivo | H2O2 or rotenone model in SH-SY5Y cells. Dieldrin model in SN4741 cells. Aged rats. | [166] |
Centella asiatica extract. | In vivo | PSAPP mice. | [92] |
Chrysanthemum morifolium extract. | In vitro | MPP+ model in SH-SY5Y cell. | [126] |
Ipomoea batatas PoirCv. | In vitro | Aβ model in PC12 cells. | [121] |
Gastrodia elata extract. | In vitro | MPP+ model in SH-SY5Y cells. | [141] |
Nobiletin, flavonoid from citrus peels. | In vitro In vivo | H2O2 model in PC12 cells. Rat artery occlusion model. | [95] |
Opuntia dillenii. | In vitro In vivo | NMDA model in cortical neurons. Rat artery occlusion model. | [169] |
Methanolic extracts from Salvia species. | In vitro | Glutamate model in PC12 cells. | [62] |
Toki-to, mixed medicinal herbs. | In vitro In vivo | 6-OHDA model in PC12 cells. 6-OHDA rat model. | [158] |
Tripterygium regelii methanolic extract. | In vitro | 6-OHDA model in mesencephalic cells. | [140] |
Vincamine from Vinca minor (Figure 2(c)). | In vivo | Mice. | [80] |
Paeonol from Paeonia suffruticosa or Paeonia lactiflora. | In vitro In vivo | MPP+ model in PC12 cells. MPP+ mice model. | [14] |
Oxyresveratrol and resveratrol from Smilacis chinae rhizome (Figure 1(c)). | In vivo | d-galactose mice model. | [171] |
Rhus verniciflua extract. | In vitro | H2O2 model in PC12 cells. | [139] |
Salvia miltiorrhiza. | In vitro In vivo | Cortical neurons overexpressing APP695. APP/PS1 transgenic mice. | [88] |
Bacopa monnieri extract. | In vivo | Aβ model in cortical neurons. | [113] |
Buddleia lindleyana. | In vivo | 6-OHDA rat model. | [145] |
Pelargonidin (Figure 1(o)). | In vivo | Ethylcholine aziridinium ion model (AF64A). | [133] |
Samjunghwan, multiherbal extract. | In vivo | Acute ischemic stroke model. | [107] |
|
Motor/cognitive improvement | Silybum marianum. | In vivo | MPTP mice model. | [172] |
Methanolic extracts from species of Salvia. | In vitro | Glutamate model in PC12 cells. | [62] |
Pedicularioside A from Buddleia lindleyana. | In vivo | 6-OHDA rat model. | [145] |
Paeonol from Paeonia suffruticosa or Paeonia lactiflora. | In vitro In vivo | MPP+ model in PC12 cells. MPP+ mice model. | [14] |
Oxyresveratrol & resveratrol from Smilacis chinae rhizome (Figure 1(c)). | In vivo | d-galactose mice model. | [171] |
Magnolia officinalis. | In vivo | SAMP8 mice. | [81] |
Cistanche salsa. | In vivo | MPP+ mice model. | [127] |
Polyphenolic compounds extracted from cocoa. | In vivo | Aged rats. | [76] |
Luteolin. | In vitro | LPS model in mesencephalic neuron-glia and microglia cells. | [143] |
Cassia obtusifolia. | In vivo | Scopolamine model. Transient cerebral hypoperfusion model. | [102] |
Dioscorea opposita. | In vitro In vivo | H2O2 or glutamate model in cortical neurons. Scopolamine mice model. | [106] |
Korean red ginseng. | Clinical trials | AD patients. | [122] |
Pelargonidin (Figures 1(d) and 1(e)). | In vivo | Ethylcholine aziridinium ion model (AF64A). | [133] |
Saussurea pulvinata. | In vivo | Aβ mice model. | [63] |
Toki-to, mixed medicinal herbs. | In vitro In vivo | 6-OHDA model in PC12 cells. 6-OHDA rat model. | [158] |
Valeriana officinalis extract. | In vivo | Tg2576 transgenic mice. | [138] |
Piperine (Figure 2(d)). | In vitro | Rotenone model in SH-SY5Y cells. | [104] |
L-theanine, from green tea (Figure 3(b)). | In vitro | H2O2 model in SH-SY5Y cells. | [16] |
|
Anti-inflammatory | Zingiberis Rhizoma hexane extract. | In vitro | LPS model in BV-2 microglia cells. | [69] |
Ficus religiosa leaf. | In vitro | LPS model in BV-2 microglia cells. | [68] |
Luteolin. | In vitro | LPS model in mesencephalic neuron-glia and microglia cells. | [143] |
Samjunghwan, multiherbal extract. | In vivo | Acute ischemic stroke model. | [107] |
Saussurea pulvinata. | In vivo | Aβ mice model. | [63] |
Silybum marianum. | In vivo | MPTP mice model. | [172] |
Rosmarinus officinalis. | In vitro | H2O2 or rotenone model in SH-SY5Y cells. | |
Dieldrin model in SN4741 cells. | [166] |
In vivo | Aged rats. | |
Nobiletin, flavonoid from citrus peels. | In vitro In vivo | H2O2 model in PC12 cells. Rat artery occlusion model. | [95] |
Cassia obtusifolia. | In vivo | Scopolamine model. Transient cerebral hypoperfusion model. | [102] |
Methoxsalen from Poncirus trifoliate. | In vivo | Trimethyltin mice model. | [15] |
Pelargonidin (Figure 1(o)). | In vivo | Ethylcholine aziridinium ion model (AF64A). | [133] |
Tripterygium regelii methanolic extract. | In vitro | 6-OHDA model in mesencephalic cells. | [140] |
|